| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 片剂产品(元) | 27,520,355.00 | 14,151,618.00 | 43,515,536.00 | 24,562,295.00 |
| 注射剂产品(元) | 17,448,365.00 | 10,784,441.00 | 23,293,813.00 | 16,589,142.00 |
| 原料药(元) | 2,588,697.00 | - | 2,410,230.00 | - |
| 其他(元) | 2,169,811.00 | 139,752.00 | 4,083,582.00 | 7,929.00 |
| 营业成本(元) | ||||
| 片剂产品(元) | 16,312,241.00 | 7,135,985.00 | 23,719,627.00 | 12,344,753.00 |
| 注射剂产品(元) | 4,590,777.00 | 2,304,789.00 | 4,708,478.00 | 2,509,275.00 |
| 原料药(元) | 2,009,258.00 | - | 1,876,157.00 | - |
| 其他(元) | - | 37,502.00 | 1,837,960.00 | 3,156.00 |
| 毛利(元) | ||||
| 片剂产品(元) | 11,208,114.00 | 7,015,633.00 | 19,795,909.00 | 12,217,542.00 |
| 注射剂产品(元) | 12,857,588.00 | 8,479,652.00 | 18,585,335.00 | 14,079,867.00 |
| 原料药(元) | 579,439.00 | - | 534,073.00 | - |
| 其他(元) | 2,169,811.00 | 102,250.00 | 2,245,622.00 | 4,773.00 |
| 毛利率(%) | ||||
| 片剂产品(%) | 40.73 | 49.57 | 45.49 | 49.74 |
| 注射剂产品(%) | 73.69 | 78.63 | 79.79 | 84.87 |
| 原料药(%) | 22.38 | - | 22.16 | - |
| 其他(%) | - | 73.17 | 54.99 | 60.20 |
| 收入构成(%) | ||||
| 片剂产品(%) | 55.34 | 56.44 | 59.36 | 59.68 |
| 注射剂产品(%) | 35.09 | 43.01 | 31.78 | 40.30 |
| 原料药(%) | 5.21 | - | 3.29 | - |
| 其他(%) | 4.36 | 0.56 | 5.57 | 0.02 |
| 毛利构成(%) | ||||
| 片剂产品(%) | 41.80 | 44.98 | 48.09 | 46.45 |
| 注射剂产品(%) | 47.95 | 54.37 | 45.15 | 53.53 |
| 原料药(%) | 2.16 | - | 1.30 | - |
| 其他(%) | 8.09 | 0.66 | 5.46 | 0.02 |